However, as has been reported, a high level of reactive oxygen species (ROS) in the tumor microenvironment (TME) is adverse to ICD via injuring HMGB1 function 9; it is essential to consume ROS and reverse the immunosuppressive effects of the TME in order to achieve ICD of tumor cells. The gene discussed is HMGB1; the disease is neoplasm.